Related Experiment Video
Updated: Jul 27, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
High expression of MDM2 protein and low rate of p21(WAF1/CIP1) expression in SCID mice Epstein Barr virus-induced
S El Mansouri1, A Martin, A Mercadier
1Service d'Hématologie Biologique, EA 1625, and Service d'Anatomie Pathologique, Hôpital Avicenne, UFR SMBH Léonard de Vinci, Université Paris XIII, Bobigny, France.
Abstract:
To study the prevalence of p53 inactivation and MDM2/p21(WAFI/CIP1) expression in severe combined immunodeficient (SCID) mice Epstein-Barr virus (EBV)-induced lymphoproliferation, 19 samples obtained after ip injection of peripheral blood mononuclear cells (PBMCs) from EBV-seropositive donors or lymphoblastoid cell lines (LCL) were analyzed. In all samples tested, overexpression of Ki-67 antigen was shown by immunohistochemistry, indicating a high proliferative index of SCID mice EBV-induced lymphoproliferation. P53 mutations were screened by functional assay in yeast in 14 samples. With this test, a p53-inactivating mutation was found in only one case; the remaining cases exhibited a wild-type p53 pattern. However, an accumulation of p53 protein was detected by immunohistochemistry in six of 19 samples. P21 expression was found in seven of 19 samples but was not correlated with the rate of p53 protein in tumors. In contrast, high levels of nuclear accumulation of MDM2 were found in all samples by immunohistochemistry. These results suggest that a high Ki-67 proliferative index in SCID mice EBV-induced lymphoproliferation is not due to the inactivation of p53 by mutation, but could be associated with an overexpression of MDM2, which would act by a p53-independent mechanism.(J Histochem Cytochem 47:1315-1321, 1999)
Insights
Epstein-Barr virus (EBV) lymphoproliferation in SCID mice shows high proliferation, but not due to p53 mutations. Overexpressed MDM2, not p53 inactivation, may drive this EBV-driven cancer growth.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Epstein-Barr virus (EBV) can induce lymphoproliferation in severe combined immunodeficient (SCID) mice.
- The role of p53 and its regulators, MDM2 and p21(WAF1/CIP1), in this process is not fully understood.
Purpose of the Study:
- To investigate the prevalence of p53 inactivation and the expression of MDM2 and p21(WAF1/CIP1) in EBV-induced lymphoproliferation in SCID mice.
Main Methods:
- Analysis of 19 SCID mouse samples with EBV-induced lymphoproliferation.
- Immunohistochemistry to assess Ki-67, p53, MDM2, and p21(WAF1/CIP1) expression.
- Functional yeast assay to screen for p53 mutations.
Main Results:
- High Ki-67 expression indicated a significant proliferative index in all samples.
- Only one sample showed a p53-inactivating mutation; p53 protein accumulation was observed in 6/19 samples.
- MDM2 nuclear accumulation was detected in all samples, while p21 expression was found in 7/19 samples without correlation to p53 levels.
Conclusions:
- High proliferation in SCID mice EBV-induced lymphoproliferation is not driven by p53 mutation.
- Overexpression of MDM2, potentially via a p53-independent pathway, may contribute to the observed lymphoproliferation.
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation

